Lexapro: Effective SSRI Treatment for Depression and Anxiety
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.87 | $38.70 (0%) | 🛒 Add to cart |
| 20 | $2.15 | $77.40 $43.00 (44%) | 🛒 Add to cart |
| 30 | $1.58 | $116.10 $47.30 (59%) | 🛒 Add to cart |
| 60 | $0.86 | $232.20 $51.60 (78%) | 🛒 Add to cart |
| 90 | $0.76 | $348.30 $68.80 (80%) | 🛒 Add to cart |
| 120 | $0.72 | $464.40 $86.00 (81%) | 🛒 Add to cart |
| 180 | $0.62 | $696.60 $111.80 (84%) | 🛒 Add to cart |
| 270 | $0.57 | $1044.90 $154.80 (85%) | 🛒 Add to cart |
| 360 | $0.51
Best per pill | $1393.20 $184.90 (87%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.30 | $43.00 (0%) | 🛒 Add to cart |
| 20 | $2.36 | $86.00 $47.30 (45%) | 🛒 Add to cart |
| 30 | $1.72 | $129.00 $51.60 (60%) | 🛒 Add to cart |
| 60 | $1.15 | $258.00 $68.80 (73%) | 🛒 Add to cart |
| 90 | $0.96 | $387.00 $86.00 (78%) | 🛒 Add to cart |
| 120 | $0.86 | $516.00 $103.20 (80%) | 🛒 Add to cart |
| 180 | $0.76 | $774.00 $137.60 (82%) | 🛒 Add to cart |
| 270 | $0.70 | $1161.00 $189.20 (84%) | 🛒 Add to cart |
| 360 | $0.63
Best per pill | $1548.00 $227.90 (85%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $1.94 | $68.80 $38.70 (44%) | 🛒 Add to cart |
| 30 | $1.43 | $103.20 $43.00 (58%) | 🛒 Add to cart |
| 60 | $0.79 | $206.40 $47.30 (77%) | 🛒 Add to cart |
| 90 | $0.57 | $309.60 $51.60 (83%) | 🛒 Add to cart |
| 120 | $0.47 | $412.80 $55.90 (86%) | 🛒 Add to cart |
| 180 | $0.33 | $619.20 $60.20 (90%) | 🛒 Add to cart |
| 270 | $0.27 | $928.80 $73.10 (92%) | 🛒 Add to cart |
| 360 | $0.23
Best per pill | $1238.40 $81.70 (93%) | 🛒 Add to cart |
Synonyms | |||
Lexapro (escitalopram oxalate) is a selective serotonin reuptake inhibitor (SSRI) approved by the FDA for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adults and adolescents. As one of the most widely prescribed antidepressants globally, Lexapro works by increasing serotonin levels in the brain, which helps improve mood, reduce anxiety, and restore emotional balance. Its favorable side effect profile and demonstrated efficacy in clinical trials make it a first-line pharmacological option for managing these common mental health conditions under proper medical supervision.
Features
- Active ingredient: Escitalopram oxalate
- Drug class: Selective serotonin reuptake inhibitor (SSRI)
- Available formulations: Oral tablets (5 mg, 10 mg, 20 mg) and oral solution (5 mg/5 mL)
- FDA-approved indications: Major depressive disorder and generalized anxiety disorder
- Half-life: Approximately 27–32 hours
- Metabolism: Primarily hepatic via CYP2C19, CYP3A4, and CYP2D6 enzymes
Benefits
- Demonstrates significant improvement in depressive symptoms within 1–2 weeks of initiation
- Reduces anxiety symptoms and improves overall quality of life in patients with GAD
- Generally well-tolerated with lower incidence of side effects compared to older antidepressants
- Once-daily dosing improves medication adherence
- Non-sedating profile allows for daytime use without significant drowsiness
- Proven efficacy in both acute treatment and maintenance therapy for relapse prevention
Common use
Lexapro is primarily prescribed for the treatment of major depressive disorder in adults and adolescents aged 12–17 years. It is also approved for generalized anxiety disorder in adults. Off-label uses may include panic disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder, though these applications require careful clinical evaluation. Treatment typically begins with low doses followed by gradual titration based on therapeutic response and tolerability.
Dosage and direction
Adults (MDD and GAD): Initial dose: 10 mg once daily. May be increased to 20 mg daily after minimum of one week based on clinical response.
Geriatric patients: Recommended starting dose: 5 mg daily.
Adolescents (12–17 years for MDD): Initial dose: 10 mg once daily. May be increased to 20 mg daily after at least three weeks.
Administration: May be taken with or without food. Tablets should be swallowed whole; oral solution should be measured with provided dosing device.
Duration: Treatment typically continues for 6–12 months after symptom remission to prevent relapse. Discontinuation should be gradual under medical supervision.
Precautions
- Monitor for worsening depression or emergence of suicidal ideation, particularly in children, adolescents, and young adults
- Use with caution in patients with history of mania/hypomania or bipolar disorder
- May cause hyponatremia, especially in elderly patients and those taking diuretics
- Use cautiously in patients with hepatic impairment; dosage reduction recommended
- May increase risk of bleeding, particularly when combined with NSAIDs, aspirin, or warfarin
- May cause activation syndrome (anxiety, agitation, panic attacks) during initial treatment phase
- Caution advised in patients with history of seizures or conditions that might predispose to seizures
Contraindications
- Hypersensitivity to escitalopram, citalopram, or any component of the formulation
- Concurrent use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy
- Concurrent use with pimozide
- Patients taking linezolid or intravenous methylene blue
- Known congenital long QT syndrome or significant cardiac arrhythmias
Possible side effects
Common (≥5%): Nausea, insomnia, ejaculation disorder, fatigue, drowsiness, increased sweating
Less common (1–5%): Diarrhea, constipation, dizziness, decreased libido, anorgasmia, appetite changes
Rare (<1%): Serotonin syndrome, QT prolongation, angle-closure glaucoma, hyponatremia, abnormal bleeding
Additional considerations: Sexual dysfunction may persist after discontinuation (Post-SSRI Sexual Dysfunction)
Drug interaction
- MAOIs: Risk of serotonin syndrome; contraindicated
- Other serotonergic drugs: Increased risk of serotonin syndrome with tramadol, triptans, other SSRIs/SNRIs
- Drugs that prolong QT interval: Additive effects with antiarrhythmics, antipsychotics, antibiotics
- CYP2C19 inhibitors: May increase escitalopram levels (e.g., omeprazole, fluconazole)
- Anticoagulants/antiplatelets: Increased bleeding risk with warfarin, NSAIDs, aspirin
- CNS depressants: Enhanced sedative effects with alcohol, benzodiazepines, opioids
Missed dose
If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose. Do not double the dose to make up for a missed dose. If vomiting occurs shortly after administration, do not retake the dose; continue with next scheduled dose. Maintain regular dosing schedule to ensure stable serum concentrations.
Overdose
Symptoms may include dizziness, sweating, nausea, vomiting, tremor, drowsiness, sinus tachycardia, and in severe cases, seizures, coma, or ECG changes. Serotonin syndrome manifestations may include hyperthermia, rigidity, myoclonus, autonomic instability. No specific antidote exists; provide supportive care and symptomatic treatment. Gastric lavage with airway protection may be considered if presented early. Activated charcoal may be administered. Monitor cardiac function and electrolytes.
Storage
Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F). Keep container tightly closed. Protect from light and moisture. Keep oral solution in original container; use within 6 months of opening. Keep all medications out of reach of children and pets. Do not use after expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Lexapro is a prescription medication that should be used only under the supervision of a qualified healthcare provider. Individual response to treatment may vary. Always consult with a healthcare professional before starting, changing, or discontinuing any medication. Do not share medication with others. Report any adverse effects to your healthcare provider promptly.
Reviews
Clinical studies demonstrate Lexapro’s efficacy with response rates of 60–70% in major depressive disorder and significant anxiety reduction in generalized anxiety disorder. Patient reviews often note improvement in mood and functionality within 2–4 weeks, though some report initial side effects that typically diminish over time. Healthcare providers frequently cite its favorable tolerability profile and once-daily dosing as advantages in long-term management of depressive and anxiety disorders.